CEO Tried AI in Drug Testing–Here’s Why It Failed

CEO Tried AI in Drug Testing–Here’s Why It Failed
Dinkar Sindhu Courtesy of Bay Area Innovators
Steve Ispas
Steve Ispas
Reporter
|Updated:
In today’s episode, Dinkar Sindhu, CEO of Axis Clinicals, dives into the world of clinical research and the cautious integration of AI in drug development.
Steve Ispas
Steve Ispas
Reporter
Steve is an investigative reporter based in the San Francisco Bay Area.